Robotic Therapy Hybridized With Mirror Therapy in Stroke Rehabilitation
Unilateral and Bilateral Approaches to Robotic Therapy Hybridized With Mirror Therapy in Stroke Rehabilitation
1 other identifier
interventional
81
1 country
2
Brief Summary
The goal of this clinical trial is to compare the effects of three groups: (1) unilateral robotic therapy with computerized visual feedback plus unilateral innovative mirror therapy, (2) bilateral robotic therapy with computerized visual feedback plus bilateral innovative mirror therapy, and (3) dose-matched conventional rehabilitation as the control. The investigators will also study the factors predictive of treatment success, identify key predictors of clinical improvement, and distinguish patient profiles most likely to benefit from each regimen. The findings of this clinical trial are expected to advance knowledge about the synergistic effects of unilateral and bilateral hybrid programs. The predictive study of treatment outcomes will inform patient selection in precision rehabilitation toward personalized stroke management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Mar 2025
Typical duration for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedStudy Start
First participant enrolled
March 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2028
March 27, 2025
January 1, 2025
3.3 years
January 10, 2025
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fugl-Meyer Assessment-Upper Extremity subscale (FMA-UE)
Baseline, 6 weeks, and 18 weeks
Secondary Outcomes (7)
Grip and pinch strength
Baseline, 6 weeks, and 18 weeks
Box and Block Test (BBT)
Baseline, 6 weeks, and 18 weeks
Revised Nottingham Sensory Assessment (rNSA)
Baseline, 6 weeks, and 18 weeks
Motor Activity Log (MAL)
Baseline, 6 weeks, and 18 weeks
ABILHAND Questionnaire
Baseline, 6 weeks, and 18 weeks
- +2 more secondary outcomes
Study Arms (3)
Unilateral RT plus unilateral innovative MT
EXPERIMENTALUnilateral robotic therapy (RT) with computerized visual feedback plus unilateral innovative mirror therapy (MT)
Bilateral RT plus bilateral innovative MT
EXPERIMENTALBilateral robotic therapy (RT) with computerized visual feedback plus bilateral innovative mirror therapy (MT)
Dose-matched conventional rehabilitation
ACTIVE COMPARATORDose-matched conventional rehabilitation as the control
Interventions
The Bi-Manu-Track (BMT) robot will be provided as the robotic practice. The BMT can be switched from the bilateral practice modules involving bilateral upper limbs to the unilateral module involving the affected upper limb. According to the group assignment, participants will practice the unilateral or bilateral module of BMT training.
The innovative mirror therapy (MT) program will be conducted with computerized mirror visual feedback and the conventional mirror box therapy. The unilateral MT group will practice on the unilateral module, while the bilateral MT group will practice based on the bilateral module. In the unilateral module, the affected hand will be static on the knee. In contrast, during bilateral MT, participants will be asked to do the same movements using the unaffected and affected arms as symmetrically as possible.
Participants in the control group will receive therapist-mediated rehabilitation per session.
Eligibility Criteria
You may qualify if:
- (1) a first ever-stroke≧3 months and less than 2 years, (2) age range between 30 to 80 years, (3) baseline Fugl-Meyer Assessment-Upper Extremity subscale (FMA-UE) between 18 to 56, (4) no excessive muscle spasticity of the affected extremities (Modified Ashworth Scale \< 3 at any joints), (5) able to follow examiners' commands and study instructions (Montreal Cognitive Assessment score≧22), and (6) no fracture of upper extremities within the past 3 months, and (7) no participation in any other experimental rehabilitation or drug studies during study period of this project.
You may not qualify if:
- (1) acute inflammation and pain, (2) receiving botulinum toxin injections within the past 3 months, and (3) concomitant neurologic, neuromuscular or orthopedic conditions that may interfere with participation in this research.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Wan Fang Hospital, Taipei Medical University
Taipei, Taiwan, Taiwan
National Taiwan University Hospital
Taipei, Taiwan, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2025
First Posted
January 16, 2025
Study Start
March 31, 2025
Primary Completion (Estimated)
July 31, 2028
Study Completion (Estimated)
July 31, 2028
Last Updated
March 27, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share